FABP4-mediated homocysteine-induced cholesterol accumulation in THP-1 monocyte-derived macrophages and the potential epigenetic mechanism

Jiang,Yideng; Ma,Shengchao; Zhang,Huiping; Yang,Xiaoling; Lu,Guan  Jun; Zhang,Hui; He,Yangyang; Kong,Fanqi; Yang,Anning; Xu,Hua; Zhang,Minghao; Jiao,Yun; Li,Guizhong; Cao,Jun; Jia,Yuexia; Jin,Shaoju; Wei,Jun; Shi,Yingkang

doi:10.3892/mmr.2016.5315

FABP4-mediated homocysteine-induced cholesterol accumulation in THP-1 monocyte-derived macrophages and the potential epigenetic mechanism

Authors:
- Yideng Jiang
- Shengchao Ma
- Huiping Zhang
- Xiaoling Yang
- Guan Jun Lu
- Hui Zhang
- Yangyang He
- Fanqi Kong
- Anning Yang
- Hua Xu
- Minghao Zhang
- Yun Jiao
- Guizhong Li
- Jun Cao
- Yuexia Jia
- Shaoju Jin
- Jun Wei
- Yingkang Shi
View Affiliations

Affiliations: Department of Cardiothoracic Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan 610000, P.R. China, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Medical Experimental Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China
Published online on: May 19, 2016 https://doi.org/10.3892/mmr.2016.5315
Pages: 969-976

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hyperhomocysteinemia (HHcy) is an independent risk factor for the development of atherosclerosis (AS), according to overwhelming number of clinical and epidemiological studies. However, the underlying pathogenic molecular mechanisms by which HHcy promotes AS remain to be fully elucidated. Fatty acid binding protein 4 (FABP4) has been shown to be important in macrophage cholesterol trafficking. The objective of the present study was to determine whether homocysteine (Hcy) accelerates AS through regulating FABP4, and then mediates cholesterol accumulation in macrophages. Hcy concentrations of 0, 50, 100, 200 and 500 µM, and 100 µM Hcy+30 µM vitamin B12 (VB12)+30 µM folic acid (FA) were respectively added to cultured THP‑1 monocyte‑derived macrophages for 24 h. The levels of FABP4, which acts as a key factor connecting cellular lipid accumulation to inflammation, were determined using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analyses in the macrophages. The present study used a nested touchdown methylation‑specific PCR assay to detect the DNA methylation status of the FABP4 promoter region. In addition, the FABP4 gene fragment was inserted into the cloning vector, pcDNA3.1‑EGFP, to construct the recombinant plasmid, pcDNA3.1‑EGFP/FABP4, which was identified using restriction endonuclease digestion analysis and DNA sequencing. The pcDNA3.1‑EGFP/FABP4 expression plasmid was transfected into THP‑1 monocyte‑derived macrophages, mediated by liposome reagent, following which the expression levels of FABP4 were detected using RT‑qPCR and western blot analyses. The present study also determined the intracellular accumulation of total cholesterol in the macrophages. The results indicated that Hcy decreased the levels of FABP4 promoter methylation, but increased the mRNA and protein expression levels of FABP4 in the macrophages, compared with the control group (0 µM Hcy). However, no dose‑dependent changes were observed with increasing concentrations of Hcy. The recombinant fluorescent eukaryotic expression vector, pcDNA3.1‑EGFP/FABP4, was successfully constructed and effectively expressed in the THP‑1 macrophages. The results also showed that FABP4 accelerated the accumulation of cholesterol in the macrophages. Taken together, the results of the present study suggested that FABP4 DNA hypomethylation induced by Hcy may be involved in the overexpression of FABP4, thereby inducing cholesterol accumulation in macrophages.

View Figures

View References

1	Furuhashi M and Hotamisligil GS: Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat Rev Drug Disc. 7:489–503. 2008. View Article : Google Scholar
2	Cabré A, Babio N, Lázaro I, Bulló M, Garcia-Arellano A, Masana L and Salas-Salvadó J: FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis. 222:229–234. 2012. View Article : Google Scholar : PubMed/NCBI
3	Furuhashi M, Ishimura S, Ota H and Miura T: Lipid chaperones and metabolic inflammation. Int J Inflam. 2011:6426122011. View Article : Google Scholar : PubMed/NCBI
4	Fu Y, Luo N and Lopes-Virella MF: Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res. 41:2017–2023. 2000.PubMed/NCBI
5	Pelton PD, Zhou L, Demarest KT and Burris TP: PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun. 261:456–458. 1999. View Article : Google Scholar : PubMed/NCBI
6	Fu Y, Luo N, Lopes-Virella MF and Garvey WT: The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis. 165:259–269. 2002. View Article : Google Scholar : PubMed/NCBI
7	Tehlivets O: Homocysteine as a risk factor for atherosclerosis: Is its conversion to s-adenosyl-L-homocysteine the key to deregulated lipid metabolism? J Lipids. 2011:7028532011. View Article : Google Scholar : PubMed/NCBI
8	Li L, Xie J, Zhang M and Wang S: Homocysteine harasses the imprinting expression of IGF2 and H19 by demethylation of differentially methylated region between IGF2/H19 genes. Acta Biochim Biophys Sin (Shanghai). 41:464–471. 2009. View Article : Google Scholar
9	Yi-Deng J, Tao S, Hui-Ping Z, Jian-Tuan X, Jun C, Gui-Zhong L and Shu-Ren W: Folate and ApoE DNA methylation induced by homo-cysteine in human monocytes. DNA Cell Biol. 26:737–744. 2007. View Article : Google Scholar : PubMed/NCBI
10	Ma S, Zhang H, Sun W, Gong H, Wang Y, Ma C, Wang J, Cao C, Yang X, Tian J and Jiang Y: Hyperhomocysteinemia induces cardiac injury by up-regulation of p53-dependent Noxa and Bax expression through the p53 DNA methylation in ApoE(−/−) mice. Acta Biochim Biophys Sin (Shanghai). 45:391–400. 2013. View Article : Google Scholar
11	Deng G, Nguyen A, Tanaka H, Matsuzaki K, Bell I, Mehta KR, Terdiman JP, Waldman FM, Kakar S, Gum J, et al: Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. Int J Cancer. 118:2999–3005. 2006. View Article : Google Scholar : PubMed/NCBI
12	Subramanyam MA, Diez-Roux AV, Pilsner JR, Villamor E, Donohue KM, Liu Y and Jenny NS: Social factors and leukocyte DNA methylation of repetitive sequences: The multi-ethnic study of atherosclerosis. PLoS One. 8:e540182013. View Article : Google Scholar : PubMed/NCBI
13	Sharma P, Senthil kumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A and Sengupta S: Mining literature for a comprehensive pathway analysis: A case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis. 5:12006. View Article : Google Scholar : PubMed/NCBI
14	Yideng J, Zhihong L, Jiantuan X, Jun C, Guizhong L and Shuren W: Homocysteine-mediated PPARalpha, gamma DNA methylation and its potential pathogenic mechanism in monocytes. DNA Cell Biol. 27:143–150. 2008. View Article : Google Scholar
15	Jiang Y, Zhang H, Sun T, Wang J, Sun W, Gong H, Yang B, Shi Y and Wei J: The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE−/− mice. Acta Biochim Biophys Sin. 44:866–875. 2012. View Article : Google Scholar
16	Liang Y, Yang X, Ma L, Cai X, Wang L, Yang C, Li G, Zhang M, Sun W and Jiang Y: Homocysteine-mediated cholesterol efflux via ABCA1 and ACAT1 DNA methylation in THP-1 monocyte-derived foam cells. Acta Biochim Biophys Sin (Shanghai). 45:220–228. 2013. View Article : Google Scholar
17	Wang XQ, Yang K, He YS, Lu L and Shen WF: Receptor mediated elevation in FABP4 levels by advanced glycation end products induces cholesterol and triacylglycerol accumulation in THP-1 macrophages. Lipids. 46:479–486. 2011. View Article : Google Scholar : PubMed/NCBI
18	Veeranna V, Zalawadiya SK, Niraj A, Pradhan J, Ference B, Burack RC, Jacob S and Afonso L: Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol. 58:1025–1033. 2011. View Article : Google Scholar : PubMed/NCBI
19	Yang AN, Zhang HP, Sun Y, Yang XL, Wang N, Zhu G, Zhang H, Xu H, Ma SC, Zhang Y, Li GZ, Jia YX, Cao J and Jiang YD: High-methionine diets accelerate atherosclerosis by HHcy-mediated FABP4 gene demethylation pathway via DNMT1 in ApoE(−/−) mice. FEBS Lett. 589:3998–4009. 2015. View Article : Google Scholar : PubMed/NCBI
20	Makowski L, Brittingham KC, Reynolds JM, Suttles J and Hotamisligil GS: The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem. 280:12888–12895. 2005. View Article : Google Scholar : PubMed/NCBI
21	Fu Y, Luo N and Lopes-Virella MF: Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res. 41:2017–2023. 2000.PubMed/NCBI
22	Miller AL: The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev. 8:7–19. 2003.PubMed/NCBI
23	Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB and Hotamisligil GS: A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci USA. 103:6970–6975. 2006. View Article : Google Scholar : PubMed/NCBI
24	Furuhashi M, Fuseya T, Murata M, Hoshina K, Ishimura S, Mita T, Watanabe Y, Omori A, Matsumoto M, Sugaya T, et al: Local production of fatty acid-binding protein 4 in epicardial/perivascular fat and macrophages is linked to coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 36:825–834. 2016. View Article : Google Scholar : PubMed/NCBI
25	Huang Y, Peng K, Su J, Huang Y, Xu Y and Wang S: Different effects of homocysteine and oxidized low density lipoprotein on methylation status in the promoter region of the estrogen receptor a gene. Acta Biochim Biophys Sin (Shanghai). 39:19–26. 2007. View Article : Google Scholar
26	Yideng J, Jianzhong Z, Ying H, Juan S, Jinge Z, Shenglan W, Xiaoqun H and Shuren W: Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol. 26:603–611. 2007. View Article : Google Scholar : PubMed/NCBI
27	Jiang Y, Sun T, Xiong J, Cao J, Li G and Wang S: Hyperhomocysteinemia-mediated DNA hypomethylation and its potential epigenetic role in rats. Acta Biochim Biophys Sin (Shanghai). 39:657–667. 2007. View Article : Google Scholar
28	Zaina S, Lindholm MW and Lund G: Nutrition and aberrant DNA methylation patterns in atherosclerosis: More than just hyperhomocysteinemia? J Nutr. 135:5–8. 2005.
29	Moore KJ and Freeman MW: Targeting innate immunity for CV benefit. Drug Discov Today Ther Strateg. 5:15–23. 2008. View Article : Google Scholar : PubMed/NCBI